Surgery

Nephron sparing surgery has excellent lasting outcomes

(HealthDay)—For patients with bilateral renal masses, nephron sparing surgery (NSS) results in excellent long-term oncological and functional outcomes and survival rates, according to a study published in the December issue ...

Oncology & Cancer

Phase III data in treatment of renal cell carcinoma reported

New results from phase III trials exploring treatment options for patients with advanced renal cell carcinoma were released at the ESMO 2012 Congress of the European Society for Medical Oncology in Vienna.

Surgery

Single-site laparoscopic surgery reduces pain of tumor removal

Researchers at the University of California, San Diego School of Medicine have found that recovery from an emerging, minimally invasive surgical technique called Laparo-Endoscopic Single-Site Surgery (LESS) was less painful ...

Medications

Afinitor approved for advanced breast cancer

(HealthDay) -- Afinitor (everolimus) has been approved in combination with the drug exemestane to treat postmenopausal women with advanced hormone-receptor positive, HER2-negative breast cancer, the U.S. Food and Drug Administration ...

Oncology & Cancer

New immune therapy shows promise in kidney cancer

An antibody that helps a person's own immune system battle cancer cells shows increasing promise in reducing tumors in patients with advanced kidney cancer, according to researchers at Beth Israel Deaconess Medical Center.

page 17 from 19